AGITATION
Clinical trials for AGITATION explained in plain language.
Never miss a new study
Get alerted when new AGITATION trials appear
Sign up with your email to follow new studies for AGITATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug calms dementia agitation in phase 3 trial
Symptom relief CompletedThis study tested a medicine called BXCL501 for calming sudden episodes of agitation in people with dementia. 151 participants took the medicine or a placebo as needed over 12 weeks. The goal was to see if the medicine safely reduces agitation symptoms like tension and hostility.
Matched conditions: AGITATION
Phase: PHASE3 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated May 26, 2026 06:40 UTC
-
Hope for Alzheimer's caregivers: new drug targets agitation
Symptom relief CompletedThis study tested an experimental drug called AXS-05 to see if it can safely reduce agitation in people with Alzheimer's disease. About 408 participants took either the drug or a placebo for several weeks. The goal was to measure changes in agitation using a standard rating scale…
Matched conditions: AGITATION
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC
-
ICU delirium drug shows promise in reducing agitation
Symptom relief CompletedThis study tested whether a sedative called dexmedetomidine can help calm agitation and shorten delirium in ICU patients who are not on a breathing machine. 168 adults with sudden confusion and agitation took part. The goal was to see if the drug could reduce the time they spent …
Matched conditions: AGITATION
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC